Search

Your search keyword '"Carcinoma, Squamous Cell pathology"' showing total 1,385 results

Search Constraints

Start Over You searched for: Descriptor "Carcinoma, Squamous Cell pathology" Remove constraint Descriptor: "Carcinoma, Squamous Cell pathology" Publisher biomed central Remove constraint Publisher: biomed central
1,385 results on '"Carcinoma, Squamous Cell pathology"'

Search Results

1. WNT7B promotes cancer progression via WNT/β-catenin signaling pathway and predicts a poor prognosis in oral squamous cell carcinoma.

2. The diagnosis value of dual-energy computed tomography (DECT) multi-parameter imaging in lung adenocarcinoma and squamous cell carcinoma.

3. Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma.

4. Clinico-pathological specificities of gingival carcinoma among 32 patients with oral cancer: a cross sectional retrospective and observational study.

5. CHRDL1 inhibits OSCC metastasis via MAPK signaling-mediated inhibition of MED29.

6. Amphiregulin promotes activated regulatory T cell-suppressive function via the AREG/EGFR pathway in laryngeal squamous cell carcinoma.

7. Prognostic value of platelet-to-lymphocyte ratio in patients with oral squamous cell carcinoma: a systematic review and meta-analysis.

8. MCPIP1 modulates the miRNA‒mRNA landscape in keratinocyte carcinomas.

9. Very pronounced bowel sparing during radiation therapy for anal carcinoma using a natural spacer (Myoma) - a case report.

10. Unveiling ficolins: diagnostic and prognostic biomarkers linked to the Tumor Microenvironment in Lung Cancer.

11. Association of serum and salivary dipeptidyl peptidase-4 (DPP-4) with oral cancerous and precancerous lesions; an observational diagnostic accuracy study.

12. Depth of invasion and extranodal extension: the influential factors to predict survival rate of patients with oral tongue squamous cell carcinoma.

13. Serum cyfra21-1 is a new prognostic biomarker of penile squamous cell carcinoma.

14. Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma.

15. The seven-day cumulative post-esophagectomy inflammatory response predicts cancer recurrence.

16. Identification of common salivary miRNA in oral lichen planus and oral squamous cell carcinoma: systematic review and meta-analysis.

17. Maximum standardised uptake value of positron emission tomography as a predictor of oesophageal cancer outcomes.

18. Characterization of prognostic signature related with twelve types of programmed cell death in lung squamous cell carcinoma.

19. Para-aortic and pelvic lymphadenectomy in locally advanced cervical cancer with pelvic lymph node metastasis.

20. Mediator complex subunit 1 promotes oral squamous cell carcinoma progression by activating MMP9 transcription and suppressing CD8 + T cell antitumor immunity.

21. LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway.

22. Lymph node metastasis diagnosis of postoperative OSCC patients by analyzing extracellular vesicles in drainage fluid based on microfluidic isolation.

23. The anticancer potential of tetrahydrocurcumin-phytosomes against oral carcinoma progression.

24. Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.

25. Long non-coding RNA PVT1 regulates TGF-β and promotes the proliferation, migration and invasion of hypopharyngeal carcinoma FaDu cells.

26. SNAI1: a key modulator of survival in lung squamous cell carcinoma and its association with metastasis.

27. Preoperative thromboelastography parameters in predicting the tumour stage of oral squamous cell carcinoma.

28. Assessment of the quality of oral squamous cell carcinoma clinical records in oral surgery with Surgical Tool for Auditing Records (STAR) scoring.

29. SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration.

30. Multi-regional genomic and transcriptomic characterization of a melanoma-associated oral cavity cancer provide evidence for CASP8 alteration-mediated field cancerization.

31. Relationship between NLR and penile squamous cell carcinoma: a systematic review and meta-analysis.

32. SEPT9: From pan-cancer to lung squamous cell carcinoma.

33. Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer.

34. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes.

35. Differences in the landscape of colonized microorganisms in different oral potentially malignant disorders and squamous cell carcinoma: a multi-group comparative study.

36. Identification and validation of autophagy-related genes influenced by paris polyphylla in tongue cancer using network pharmacology.

37. A novel nomogram for predicting overall survival in patients with tongue squamous cell carcinoma using clinical features and MRI radiomics data: a pilot study.

38. Discrimination of healthy oral tissue from oral cancer based on the mean grey value determined by optical coherence tomography.

39. Identification of diagnostic biomarkers and immune cell infiltration in tongue squamous cell carcinoma using bioinformatic approaches.

40. Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma.

41. The spatial distribution of intermediate fibroblasts and myeloid-derived cells dictate lymph node metastasis dynamics in oral cancer.

42. Spindle epithelial tumor with thymus-like elements (SETTLE): a diagnostic challenge with distinct therapeutic implication; case report.

43. Exploring the prognostic landscape of oral squamous cell carcinoma through mitochondrial damage-related genes.

44. Effect of short-term fasting on the cisplatin activity in human oral squamous cell carcinoma cell line HN5 and chemotherapy side effects.

45. Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery.

46. Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair study.

47. Deliberation concerning the role of M1-type macrophage subset in oral carcinogenesis.

48. The efficacy and potential mechanisms of pyrotinib in targeting EGFR and HER2 in advanced oral squamous cell carcinoma.

49. FAM65A promotes the progression and growth of lung squamous cell carcinoma in vivo and vitro.

50. Clinicopathological characteristics and prognosis of non-small cell lung cancer in Algeria: a single-center retrospective study.

Catalog

Books, media, physical & digital resources